SCHEMBL27675779

SCHEMBL27675779

CC(=O)NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.60
▸ SLC6A5 Q9Y345 1/20 0.60
▸ QPCT Q16769 1/20 0.56
▸ QPCTL Q9NXS2 1/20 0.56
▸ ITGB2 P05107 3/20 0.55
▸ ICAM1 P05362 3/20 0.55
▸ ITGAL P20701 3/20 0.55
▸ SLC15A2 Q16348 1/20 0.50
▸ CA1 P00915 3/20 0.49
▸ CA2 P00918 3/20 0.49
▸ CYP3A4 P08684 3/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ SLC7A5 Q01650 1/20 0.47
▸ AGTR2 P50052 1/20 0.45
▸ F2 P00734 2/20 0.44
▸ PRSS1 P07477 2/20 0.44
▸ PRSS2 P07478 2/20 0.44
▸ PRSS3 P35030 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3057446 1.00 EPHX2 (0.60) EPHX2SLC6A5QPCTQPCTLITGB2
SCHEMBL29615190 1.00 EPHX2 (0.60) EPHX2SLC6A5QPCTQPCTLITGB2
SCHEMBL18381375 0.93 EPHX2 (0.67) EPHX2SLC6A5QPCTQPCTLITGB2
SCHEMBL28459868 0.92 SLC15A2 (0.53) EPHX2SLC6A5QPCTQPCTLITGB2
SCHEMBL23787478 0.88 QPCT (0.53) EPHX2SLC6A5QPCTQPCTLITGB2
SCHEMBL23787348 0.88 QPCT (0.53) EPHX2SLC6A5QPCTQPCTLITGB2
SCHEMBL18676311 0.88 SLC6A5 (0.59) EPHX2SLC6A5QPCTQPCTLITGB2
SCHEMBL16364167 0.88 SLC6A5 (0.62) EPHX2SLC6A5ITGB2ICAM1ITGAL
SCHEMBL15412853 0.88 EPHX2 (0.49) EPHX2SLC6A5QPCTQPCTLITGB2
SCHEMBL20384898 0.88 EPHX2 (0.49) EPHX2SLC6A5QPCTQPCTLITGB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4039248-B1 OPHTHALMIC COMPOSITION ZAKL FARMACEUTYCZNE POLPHARMA S A (PL) 2026-01-28 — — EP claimed
EP-4260070-B1 DIAGNOSIS OF AUTISM SPECTRUM DISORDER STALICLA S A (CH) 2025-09-24 — — EP claimed
US-20250170166-A1 HYALURONIC ACID HYDROGEL FORMULATION COMPRISING PHYTOESTROGEN FOR THE TREATMENT OF VAGINAL ATROPHY AND VAGINAL REJUVENATION AND PRODUCTION METHOD THEREOF VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI (TR) 2025-05-29 — — US claimed
EP-4482581-A1 HYALURONIC ACID HYDROGEL FORMULATION COMPRISING PHYTOESTROGEN FOR THE TREATMENT OF VAGINAL ATROPHY AND VAGINAL REJUVENATION AND PRODUCTION METHOD THEREOF VSY Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi (TR) 2025-01-01 — — EP claimed
US-20240415872-A1 OPHTHALMIC FORMULATIONS FOR TREATMENT OF PRESBYOPIA, DRY EYE DISEASE AND COMPUTER VISION SYNDROME VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI (TR) 2024-12-19 — — US claimed
US-20240408118-A1 AN OPHTHALMIC FORMULATION FOR TREATMENT AND PREVENTION OF CATARACT AND PRODUCTION METHOD THEREOF VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI (TR) 2024-12-12 — — US claimed
EP-4426316-A1 RHEOLOGICALLY SYNOVIAL FLUID-LIKE HYDROGEL FORMULATIONS FOR USING IN INTRA-ARTICULAR APPLICATIONS VSY Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi (TR) 2024-09-11 — — EP claimed
EP-4419204-A1 AN OPHTHALMIC FORMULATION FOR TREATMENT AND PREVENTION OF CATARACT AND PRODUCTION METHOD THEREOF VSY Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi (TR) 2024-08-28 — — EP claimed
EP-4419145-A1 OPHTHALMIC FORMULATIONS FOR TREATMENT OF PRESBYOPIA, DRY EYE DISEASE AND COMPUTER VISION SYNDROME VSY Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi (TR) 2024-08-28 — — EP claimed
EP-4326284-A1 INJECTABLE HYALURONIC ACID FORMULATIONS FOR USE IN INTRAARTICULAR, INTRADERMAL AND OPHTHALMIC APPLICATIONS VSY Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi (TR) 2024-02-28 — — EP claimed
WO-2023069036-A1 AN OPHTHALMIC FORMULATION FOR TREATMENT AND PREVENTION OF CATARACT AND PRODUCTION METHOD THEREOF VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI (TR) 2023-04-27 — — WO claimed
CN-112659955-B Two-dimensional matrix type charging stack power distribution device and control method thereof 国网湖北省电力有限公司电力科学研究院 2023-02-03 — — CN claimed
WO-2022225476-A1 INJECTABLE HYALURONIC ACID FORMULATIONS FOR USE IN INTRAARTICULAR, INTRADERMAL AND OPHTHALMIC APPLICATIONS VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI (TR) 2022-10-27 — — WO claimed
WO-2022123057-A1 DIAGNOSIS OF AUTISM SPECTRUM DISORDER STALICLA SA (CH) 2022-06-16 — — WO claimed
CN-110404057-A A kind of pharmaceutical composition and its application based on gene recombinant protein Tat-hMsrA WUHAN HUATAI BIOTECHNOLOGY CO LTD 2019-11-05 — — CN claimed
CN-109820767-A A kind of skin caring material and preparation method thereof 黄丽娜 2019-05-31 — — CN claimed
CN-105153038-B A kind of synthetic method of N acetyl carnosines 上海予利化学科技有限公司 2017-07-04 — — CN claimed
CN-106061490-A Method and composition for treating and preventing symptoms or signs of ocular diseases 列奥尼达斯·A·约翰逊 2016-10-26 — — CN claimed
CN-105902997-A Eyedrops prepared from Noni flowers and fruits, N-acetyl carnosine and hyaluronic acid and preparation method 刘海瑗 2016-08-31 — — CN claimed
CN-105153038-A Synthetic method for N-acetyl carnosine SHANGHAI YURLIC CHEMICAL S&T CO LTD 2015-12-16 — — CN claimed
Send feedback